Sub-tenon drug delivery

A - Human Necessities – 61 – F

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61F 9/00 (2006.01)

Patent

CA 2383572

Drug delivery cannulae (50) are disclosed. One embodiment of a cannula includes a distal portion (52) having a radius of curvature substantially equal to a radius of curvature of the globe of the human eye, a proximal portion (54), and a bend separating the distal portion and the proximal portion. A tangent (72) of the distal portion at the bend is disposed at an angle of no more than about 56 degrees with respect to the proximal portion. The cannulae are capable of sub-Tenon drug delivery to the posterior segment of the human eye proximate the macula.

L'invention concerne des canules (50) d'administration de médicaments. Un mode de réalisation d'une canule comprend une partie distale (52) présentant un rayon de courbure sensiblement égal à un rayon de courbure du globe de l'oeil humain, une partie proximale (54) ainsi qu'une courbure séparant la partie distale de la partie proximale. Une tangente (72) de la partie distale, au niveau de la courbure, est disposée en un angle ne dépassant pas environ 56 DEG par rapport à la partie proximale. Les canules sont capables d'une administration sous-tendineuse de médicaments au segment postérieur de l'oeil humain près de la macula.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sub-tenon drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sub-tenon drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sub-tenon drug delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1639964

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.